We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 17

WHO reports first documented human case of avian influenza A
  • Shook Hardy & Bacon LLP
  • China, USA
  • December 20 2013

The World Health Organization (WHO) has reported the first documented case of avian influenza A (H10N8) in a human patient from Jiangxi Province


Asia’s biomedical R&D spend rises, while U.S. investment declines
  • Shook Hardy & Bacon LLP
  • China, USA
  • January 9 2014

Researchers have found that the U.S. global share of biomedical research expenditures fell from 51 percent in 2007 to 45 percent in 2012, while China


China’s medical device regulations take effect June 1
  • Shook Hardy & Bacon LLP
  • China
  • May 1 2014

According to news sources, China's amended medical device rules, which increase fines for illegal manufacturing and strengthen government oversight


Engineered avian and swine flu hybrids raise concerns about mammal-to-mammal transmission
  • Shook Hardy & Bacon LLP
  • China
  • May 10 2013

Chinese scientists investigating the spread of airborne influenzas have reportedly combined genetic material from avian (H5N1) and swine (H1N1) flu


WHO issues global alert on new strain of avian influenza (H7N9)
  • Shook Hardy & Bacon LLP
  • China, Global, USA
  • April 12 2013

The World Health Organization (WHO) has issued a global alert and response update on a new strain of novel avian influenza A (H7N9) virus identified


Chinese billionaire backs U.S.China biopharma venture
  • Shook Hardy & Bacon LLP
  • China, USA
  • April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks


Medicinova and Zhejiang Medicine announce joint venture in China
  • Shook Hardy & Bacon LLP
  • China, USA
  • March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China


Chinese health officials investigate infant formula linked to early onset puberty
  • Shook Hardy & Bacon LLP
  • China
  • August 13 2010

The Chinese Ministry of Health has apparently announced an investigation into claims linking infant formula manufactured by Synutra International, Inc., to early onset puberty


Premature development causes unease in China
  • Shook Hardy & Bacon LLP
  • China, USA
  • August 20 2010

Chinese health experts have reportedly estimated that "at least 30,000 children developed early maturity" in Shanghai alone, raising concerns about food additives and pesticides allegedly laden with sex hormones


Cuba, China agree to strengthen biotechnology collaboration
  • Shook Hardy & Bacon LLP
  • China, Cuba
  • December 15 2011

Cuba and China have reportedly signed agreements to deepen their collaboration on biotechnology